Page last updated: 2024-09-03

omega-n-methylarginine and sk&f-38393

omega-n-methylarginine has been researched along with sk&f-38393 in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(sk&f-38393)
Trials
(sk&f-38393)
Recent Studies (post-2010) (sk&f-38393)
4,4113443362,01229242

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)sk&f-38393 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 22.8
DRattus norvegicus (Norway rat)0.19

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alonso, R; Emonds-Alt, X; Le Fur, G; Rodier, D; SoubriƩ, P; Souilhac, J; Steinberg, R1

Other Studies

1 other study(ies) available for omega-n-methylarginine and sk&f-38393

ArticleYear
Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation.
    Neuroscience, 1998, Volume: 84, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Corpus Striatum; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Kinetics; Male; Methylurea Compounds; Microdialysis; Morpholines; Neurotensin; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Neurokinin-2

1998